Company: BIAF
Filing Date: 2025-06-27
Form Type: POS AM
Source: 0001641172-25-016927
Chunk: 2

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-06-27
Form: POS AM
Chunk 2
---
 as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until the Registration Statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.

<div align='center'>EXPLANATORY NOTE</div>

On April 4, 2024, bioAffinity Technologies, Inc. (the “Company”) filed a Registration Statement on Form S-1 (Registration No. 333-278512), which was subsequently declared effective by the SEC on April 15, 2024 (the “April 2024 Registration Statement”).

On September 11, 2024, the Company filed a Registration Statement on Form S-1 (Registration No. 333-282045), which was subsequently declared effective by the SEC on September 19, 2024 (the “September 2024 Registration Statement”).

On November 27, 2024, the Company filed a Registration Statement on Form S-1 (Registration No. 333-283521), which was subsequently declared effective by the SEC on December 6, 2024. Pursuant to Rule 429 under the Securities Act, the prospectus contained in this Registration Statement will be used as a combined prospectus in relation with (i) this Registration Statement, (ii) the April 2024 Registration Statement, and (iii) the September 2024 Registration Statement (the registration statements referenced in clauses (i), (ii) and (iii) collectively referred to as the “2024 Resale Registration Statements”). This Registration Statement constitutes Post-Effective Amendment No. 1 to this Registration Statement, constitutes Post-Effective Amendment No. 1 to the April 2024 Registration Statement, and constitutes Post-Effective Amendment No. 1 to the September 2024 Registration Statement. Such Post-Effective Amendments will become effective concurrently with the effectiveness of this Registration Statement in accordance with Section 8(c) of the Securities Act. This filing is being made to: (i) combine the prospectuses included in the 2024 Resale Registration Statements pursuant to Rule 429 of the Securities Act, and (ii) serve as a Section 10(a)(3) update to the 2024 Resale Registration Statements and to make certain other updates to the prospectus that forms a part of this Post-Effective Amendment. Pursuant to Rule 416